Enlivex Ltd. (ENLV)
NCM – Real vaqt narxi. Valyuta: USD
0.57
-0.01 (-1.81%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.57
+0.00 (0.18%)
Bozordan keyin: Jun 26, 2026, 7:54 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
0.57
-0.01 (-1.81%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.57
+0.00 (0.18%)
Bozordan keyin: Jun 26, 2026, 7:54 PM EDT
Enlivex Ltd. o'z sho'ba korxonalari bilan birgalikda Isroilda makrofag reprogrammasi immunoterapiyasi bo'yicha klinik bosqichda faoliyat yuritadi. U makrofag gomeostazini tiklash uchun mo'ljallangan hujayrali terapiya AllocetraTMni taklif qiladi, shuningdek, 1/2 bosqich sinovlarida bo'lgan tizza osteoartritini davolash uchun AllocetraTM intra-artikulyar in'ektsiyasini; temporomandibular bo'g'im (TMJ) osteoartritida intra-artikulyar AllocetraTMni; va 2-bosqichda bo'lgan kattalar sepsis bemorlarida organ etishmovchiligini davolash uchun Allocetra-OTSni ishlab chiqadi. Enlivex Ltd. ilgari Enlivex Therapeutics Ltd. nomi bilan tanilgan va 2026 yil fevral oyida Enlivex Ltd. nomini o'zgartirgan. Kompaniya 2005 yilda tashkil etilgan va shtab-kvartirasi Isroilning Ness Ziona shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Einat Galamidi M.D. | Chief Medical Officer |
| Dr. Oren Hershkovitz Ph.D. | Chief Executive Officer |
| Dr. Veronique Amor-Baroukh | Senior Director of Operations |
| Mr. Shai Novik M.B.A. | Executive Chairman |
| Ms. Shachar Shlosberger CPA | Chief Financial Officer |
| Ms. Sigal Arad | Director of Human Resources |
| Prof. Dror Mevorach M.D. | Founder & Scientific Advisor |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-24 | 6-K | ea0295702-6k_enlivex.htm |
| 2026-06-22 | 6-K | ea0295405-6k_enlivex.htm |
| 2026-05-28 | 6-K | ea0292428-6k_enlivex.htm |
| 2026-05-27 | 6-K | ea0292240-6k_enlivex.htm |
| 2026-05-18 | 6-K | ea0291229-6k_enlivex.htm |
| 2026-05-15 | 6-K | ea0290815-6k_enlivex.htm |
| 2026-04-28 | CORRESP | filename1.htm |
| 2026-04-21 | F-3 | ea0286920-f3_enlivex.htm |
| 2026-04-21 | 6-K | ea028706001-6k_enlivex.htm |
| 2026-04-08 | 6-K | ea0285376-6k_enlivex.htm |